Leveraging its integrated "design-synthesis-quality control" system, Creative Biolabs is overcoming bottlenecks in mRNA ...
The merger process reached its formal conclusion on January 6, 2026, with Mainz-based BioNTech SE becoming the sole owner. The operational entity, CureVac Merger B.V., has replaced the original ...
AZoLifeSciences on MSN
Single enzyme enables low-cost synthesis of all RNA nucleotides
A single enzyme that can generate all four nucleotide triphosphates, the building blocks of ribonucleic acid (RNA), was ...
Researchers identified a polyphosphate kinase that converts nucleotide precursors into all four RNA nucleotides in one step. Using inexpensive polyphosphate, the enzyme enables low-cost, efficient NTP ...
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The ...
What just happened? TSMC has begun volume production of chips based on its N2 process technology, marking a major new step in 2nm-class node manufacturing. The company disclosed the milestone on its ...
The development of lithium-7 fluoride production technology is seen as a key step in Russia for the proposed future molten salt reactors. (Image: Rosatom) There is currently no industrial production ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results